Sodium sodium tablets 1.5mg/10mg Servier treat hypertension (6 blisters x 5 tablets)
Dosage form Box of 6 blisters x 5 tablets
Specifications Indapamide, amlodipine
Ingredient
| Composition information | Content |
| Indapamide | 1.5mg |
| Amlodipine | 10mg |
Uses
Indications
Sodium -drugs are indicated for replacement in the treatment of hypertension for patients who have used indepamide and amlodipine separately with the same content.
Pharmacokic of
indapamide is a sulfonamide derivative with indol nucleus, pharmacological effect is similar to thiazide diuretics, which inhibit the reabsorption of sodium in the dilution stage of the kidney shell. The drug increases sodium, chlored and increased sodium ions at a lesser level for potassium and magnesi, thus increasing the urology and has the effect of lowering blood pressure.
Amlodipine is a calcium channel blocker of the dihydropyridine group (slow channel blockage or calcium ion antagonist) and inhibit the flow of calcium ionic membranes into the heart muscle and blood vessel muscles.
ANGLODIPINE's anti -hypertension effect is due to the effect of direct relaxation of blood vessel muscles.
pharmacokinetics
simultaneous use of indapamide and amlodipine does not change the pharmacokinetic properties when compared to individual drugs.
indapamide:
IndaPamide 1.5 mg is provided in the form of prolonged release dose based on the core (Matrix), in which the active ingredient is dispersed in the carrier that allows the release of slowly indepamide.
absorption
The release of IndiaMide is absorbed quickly and completely through the digestive tract. Food slightly increases the absorption rate but does not affect the active ingredient is absorbed. The peak concentration in the serum after the single dose appears about 12 hours after oral, the dose reduces the oscillation of the serum concentration between the two doses. There is oscillation between individuals.
Distribution
The ratio of cohesion to the plasma protein of indapamide is 79%. Stable state achieved after 7 days. Repeated dose does not cause cumulative drugs.
Elimination
Mainly excreted drugs (70% dose) and feces (22%) in the form of non -active metabolites. Selling time for plasma is 14–24 hours (average 18 hours).
Pharmacokinetic parameters do not change in patients with renal failure.
amlodipine:
Amlodipine is provided in the form of instantaneous release.
absorption
After taking the dose of treatment, Amlodipine is well absorbed with peak concentration in the blood for 6 - 12 hours. Absolute bioavailability is estimated in about 64–80%. Amlodipine's bioavailability is not affected by food.
Distribution
The distribution volume is about 21 l/kg. In vitro studies show that about 97.5% amlodipine circulating in the circulation associated with plasma proteins.
Metabolism - except for
The end of the phase of the drug in plasma is about 35–50 hours and is consistent with the one -time dosage of the day. Amlodipine is metabolized mainly in the liver into non -active metabolites with 10% of the mother medicine and 60% of the metabolites are eliminated through the urine.
Before taking Sodium sodium tablets 1.5mg/10mg Servier treat hypertension (6 blisters x 5 tablets)
How to use
oral drugs. The drug should be taken in the morning. Take intact tablets with water, do not chew the medicine.
Dosage
Take 1 capsule/time x 1 time/day.
Fixed dose combination form is not suitable for the initial treatment. Only used for patients who used indepamide and amlodipine separately have the same content.
If it is necessary to adjust the dose, dose adjustment on each component by using the component single tablets.
Children
Safety and effectiveness of sodiums in children and minors have not been established. There is no data.
Elderly
Can be treated with sodium sodium depending on the kidney function.
Patients with renal failure
In patients with severe renal impairment (creatinine clearance below 30 ml/min), contraindicated treatment with sodium. In patients with mild to moderate renal failure, no dose adjustment.
Patients with liver failure
In patients with severe liver failure, contraindicated use of sodiumamam. The recommended dose of Amlodipine has not been set in patients with mild to moderate liver failure, so it is necessary to be cautious when choosing the dose and need to start at a low dose below the allowed dose range.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.
What to do when overdose?
indapamide
Initial measures include quickly eliminating substances into the digestive system by gastrointestinal and/or drinking activated carbon, then restoring the water/electrolyte balance back to normal at a specialized medical center.
amlodipine
Clinical hypotension clinically due to amlodipine overdose requires supportive support activities for cardiovascular and respiratory function regularly, the edema of the limbs and paying attention to the volume of circulation and urine. Using a vasoconstriction may be useful in restoring blood vessel and blood pressure in the absence of contraindications.
Intravenous calcium infoica can be effective against the effects of calcium channel blockers. Gastrointestinal lavage may be valid in some cases. On healthy volunteers, the use of activated carbon up to 2 hours after using amlodipine 10 mg reduces Amlodipine's absorption rate. Dialysis is not effective due to amlodipine attached to plasma proteins.
What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.
Side Effects
When using sodiums, you may experience unwanted effects (ADR).
The unwanted effects are the most common reports of indapamide and amlodipine include hypokalemia, drowsiness, dizziness, headache, vision impairment, double vision, chest drum, blushing, shortness of breath, abdominal pain, nausea, indigestion, changing the habits of the intestines, diarrhea, constipation, lumpy bodies, swollen legs, and fatigue.
Instructions on how to handle ADR
When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
Sodium -to -contraindicated drugs in the following cases:
Precautions for use
When the liver is impaired, thiazide diuretics can cause liver's brain disease, especially in the case of electrolyte imbalance. Due to the presence of indapamide, it is necessary to stop drinking sodiums immediately if this situation occurs.
Light sensitivity:
There have been reports on light sensitivity reactions caused by thiazide and diuretics related to Thiazide. If the light sensitive reaction occurs during treatment, the patient is recommended to stop treatment. If the use of diuretics is supposed to be necessary, the patient is recommended to protect the skin -exposed skin areas or artificial UVA rays.
Hypertension:
Safety and effectiveness of amlodipine on unpaid hypertension.
Water and electrolyte balance:
Plasma potassium: Hypotension is the main risk when taking thiazide diuretics and diuretics related to the Thiazide group. It is necessary to prevent the risk of reducing the concentration of potassium potassium (
Patients with long QT are also at risk, although the cause is congenital or due to treatment. Hypotension as well as slow heart rate will be a factor that promotes the risk of serious arrhythmia, especially the risk of torsion, which can lead to death.
In all above, it is necessary to regularly check the concentration of potassium. The first measurement of blood potassium should be conducted in the first week of treatment. If the concentration of low blood potassium is detected, it is necessary to adjust.
Blood glucose:
Due to the presence of indapamide, control of blood glucose levels is important in patients with diabetes, especially when low blood potassium concentration.
heart failure:
Patients with heart failure should be treated carefully. In a long -term study with a place of placebo in patients with severe heart failure (NYHA level III and IV level), pulmonary edema occurs at a higher frequency in the amlodipine treatment group compared to the control group. Calcium channel blockers including amlodipine should be used carefully in patients with congestive heart failure, because these drugs may increase the risk of cardiovascular events and death afterwards.
Kidney function:
Uric acid:
Due to the presence of indapamide, the risk of gout can increase in patients with hyperuricemia.
Liver function:
Elderly:
Need to be treated with sodiumams depending on the kidney function.
Do not use sodiums for patients with rare genetic problems galactose intolerance, lactase deficiency or glucose -galactose.
.The ability to drive and operate machinery
Sodium sodium has a slight impact on the average to drive and operate machinery.Despite the low risk of indapamide, the various reactions related to hypotension in some patients, especially in the early stages of treatment or when the patient uses another lower blood pressure. Therefore, the ability to drive and operate machinery can be affected.
Amlodipine may have light to medium influences on the ability to drive and operate machinery. If the patient uses amlodipine with symptoms of dizziness, headache, fatigue or nausea, the ability to react may be affected. Precautions especially in the first stage of treatment.
Pregnancy
do not recommend using sodiums for pregnant women.
Breastfeeding period
Contraindications to use sodiums when breastfeeding.
Drug interaction
indapamide:
Unreasonable coordination
Lithi: Lithi increases plasma lithiums with symptoms of overdose, similar to salt -free diet (excretion of lithiums through the urinary tract decreases). However, if you need diuretics, it is necessary to strictly control the plasma lithium levels and need to adjust the dose.
Caution should be careful
Peaks that cause torsion: IIA anti -arrhythmic drugs (Quinidine, hydroquinidine, disopyramide), Ili anti -arrhythmic drugs (amiodarone, sotalol, dofetilide, ibutilide), some anti -psychotic drugs (phenothiazine drugs (chlorpromazine, cyamemazine, levomemazine, levomemazine, levomemazine, levomemazine, levomemazine, levomemazine Thioridazine, trifluoperazine), Benzamide groups (Amisulpride, Sulpiride, Sultopride, Tiapride), Butyrophenone groups (Droperidol, Haloperidol)), Bupridil, Cisaprid, Diphemanil, Erythromycin intravenous sugar, Halofantrin, Mizolastin, Mizolastin, Mizolastin, Mizolastin, Mizolastin, Mizolastin, Mizolastin Pentamidin, parfloxacin, moxifloxacin, venous vannine.
Increased risk of ventricular arrhythmia, especially torsion (decreased potassium is a danger factor). It is necessary to control hypokalemia and adjust if necessary before using this combination form. Clinical control, electrolytes in plasma and electrocardiograms. Use substances that are not at risk of torsion when you are in a state of hypokalemia.
Angiotensin transferring enzyme inhibitors: The risk of sudden hypotension and/or acute renal failure when treated with an enzyme inhibitor appears when the patient is having sodium loss (especially in patients with kidney stenosis).
In patients with hypertension, when the previous diuretic treatment can cause sodium loss, it is necessary to stop diuretics 3 days before starting treatment with enzyme inhibitors and start using potassium -lowering diuretics if necessary; Or use the low starting dose to inhibit the enzyme inhibitors and increase the dose gradually.
In patients with congestive heart failure, starting treatment with very low doses of enzyme inhibitors, maybe after reducing the dose of potassium diuretics simultaneously.
In general, it is necessary to control kidney function (creatinine plasma) in the first weeks that start treatment with transferred enzyme inhibitors.
allopurinol: Concomitant treatment with indapamide may increase the risk of sensitive reactions to allopurinol.
Coordination should be considered
Calcium (salt form): The risk of hypercalcemia due to a decrease in calcium secretion through urine.
cyclosporin, tacrolimus: The risk of increased plasma creatinine is not accompanied by any changes in cyclosporin levels during circulation, even the case of patients not dehydrated or sodium loss.
amlodipine:
Dantrolen (transmission form): on animals, ventricular and cardiovascular collapse leads to deaths that have been recorded related to hyperkalemia when combining Verapamil and intravenous dantrolen. Due to the risk of hyperkalemia, it is recommended to avoid simultaneous use of calcium channel blockers such as amlodipine with dantrolen in patients with the ability to increase malignant body temperature and in the treatment of malignant body temperature.
It is not recommended to simultaneously use amlodipine along with grapefruit or grapefruit juice due to the use of the drug can increase in some patients, leading to an increase in the effect of reducing blood pressure.
CYP3A4 inhibitors:
Simultaneous use of amlodipine with strong or medium inhibitors CYP3A4 (Protease inhibitors, Azole antifungal drugs, macrolids such as erythromycin and Clarithromycin, Verapamil or Diltiazem) can significantly increase amlodipine levels in circulation. Clinical manifestations corresponding to this pharmacokinetic change of the drug can be more clear in elderly patients. Therefore, clinical monitoring and dose adjustment.
Increased risk of hypotension in patients taking clarithromycin along with amlodipine. It is recommended to closely monitor patients with simultaneous use of amlodipine with clarithromycin.
CYP3A4 induction drugs:
There is no data on the effects of CYP3A4 induction drugs with amlodipine. Used with CYP3A4 induction drugs (Rifampicin, Hypericum Perforatum) can reduce amlodipine levels in plasma. Should be cautious when taking amlodipine and drugs causing CYP3A4.
The impact of amlodipine on other drugs:
AMLODIPINE's blood pressure reduction effect resonates with the impact of reducing blood pressure of other anti -hypertension drugs.
In clinical drug interactive studies, Amlodipine does not affect the pharmacokinetics of Atorvastatin, Digoxin, Warfarin.
tacrolimus:
The risk of increased blood tacrolimus concentration when used with amlodipine. To avoid the toxicity of Tacrolimus, the use of Amlodipine in patients who used Tacrolimus should monitor the concentration of Tacrolimus in the blood and adjust the dose of Tacrolimus if necessary.
cyclosporin:
No drug interaction studies have been conducted with cyclosporin and amlodipine in healthy volunteers or other populations, except for kidney transplant patients, but the base concentration of cyclosporin increases (average 0–40%) observed. Cyclosporine concentration should be monitored in kidney transplant patients using amlodipine, and should reduce the dosage of cyclosporin if necessary.
Simvastatin:
Simultaneous use of Amlodipine 10 mg repeated doses and 80 mg of simvastatin increases 77% of simvastatin concentration in the circulation compared to when using Simvastatin alone. In patients with amlodipine, the maximum dose of simvastatin is 20 mg/day.
Storage
Store under 30ºC.
Do not use the drug after the expiry date recorded on the box and blister.
Do not pour medicine through wastewater or domestic waste. Ask your pharmacist how to handle if you don't use the drug anymore. This will help protect the environment.
Other drugs
- ETORICOXIB 120MG TABLETS
- GLYFORMIN / METFORMIN
- Iscover
- PHENOBARBITONE 30 MG TABLETS
- SEVEN SEAS ONE A DAY PURE COD LIVER OIL CAPS
- VERSATIS 5% MEDICATED PLASTERS
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions